BioCentury
ARTICLE | Finance

China-India Importer

Generic injectable company Sagent files for an IPO of up to $100M

December 13, 2010 8:00 AM UTC

Generic injectable play Sagent Holding Co.filed for an IPO of up to $100 million last week. The company markets 21 products, with a pipeline of an additional 45 products represented by 77 ANDA filings that the company expects will all be launched by YE12.

Sagent has invested about $25 million into a joint venture with Chengdu Konghong Technology Group Co. Ltd. to build a manufacturing facility in Chengdu, China. Preliminary operations are planned for next year, with an FDA inspection as early as 2012. The company has another JV with Indian manufacturer Strides Arcolab Ltd., upon which it has spent about $3 million...